On Shark Tank India Season 5, Ayuvya entered the Tank with something most startups dream of—strong revenue, fast growth, and bold projections. With Rs 51.5 crore in annual sales already on the books, the founders expected numbers to do most of the talking.
Instead, they walked out without a deal.
What began as a high-energy pitch soon turned into a tough interrogation around trust, transparency, and responsibility—especially when it comes to selling health and wellness products. By the end of the discussion, it became clear that for the Sharks, revenue alone was not enough.
The Pitch That Started Strong
Ayuvya was founded by Tanishk Pandey, Astha Jain, and Pawanjot Kaur as an ayurvedic wellness brand. The founders also operate a sister brand called ImFresh, and together they pitched both businesses as a single opportunity.
The Ask and Valuation
The founders asked for Rs 1 crore in exchange for 0.5% equity, valuing the combined business at Rs 200 crore. It was an ambitious valuation, but the founders were confident their numbers would justify it.
When they revealed their revenue figures, the room took notice.
Impressive Revenue Numbers Grab Attention
Ayuvya reported Rs 51.5 crore in revenue for FY24–25 and projected Rs 70 crore for the following year. For a wellness brand in a competitive market, those numbers were undeniably impressive.
Early Excitement in the Tank
The Sharks initially appeared impressed. High revenue often signals strong demand, effective marketing, and a product-market fit. Expectations rose quickly, and the founders seemed to have the room on their side.
But the excitement didn’t last long.
Questions Around Growth and Sustainability
Kunal Bahl was the first to dig deeper into the numbers. While revenue looked strong, he wanted to understand the quality of that growth.
Is the Growth Slowing?
Kunal asked whether Ayuvya’s growth rate was slowing compared to previous years. He also questioned customer repeat rates—an essential metric for wellness brands that rely on long-term consumption rather than one-time purchases.
The founders struggled to give clear, confident answers.
Why This Raised Red Flags
For investors, revenue without clarity can be risky. If growth is slowing or customers are not returning, future earnings may not be sustainable. The lack of detailed insight into customer behavior made the Sharks uneasy.
This was the first sign that the pitch might not go as smoothly as expected.
Marketing Strategy Comes Under Fire
As the discussion moved on, Aman Gupta turned his attention to Ayuvya’s marketing.
Criticism of Social Media Ads
Aman criticized the brand’s advertisements, calling them poor in quality and unpolished. In his view, the ads did not match the scale or credibility suggested by the company’s revenue.
Tanishk defended the strategy by saying that “ugly ads” were currently trending and performed better because they felt more authentic and relatable.
Sharks Remain Unconvinced
The Sharks weren’t sold on the explanation. While performance marketing trends change, they felt a health and wellness brand needs to inspire confidence and professionalism, not just clicks.
This exchange further weakened the founders’ position.
The Clinical Trials Question Changes Everything
The most critical moment of the pitch came when the discussion shifted to product validation.
No Clinical Trials for Ayurvedic Products
The Sharks learned that none of Ayuvya’s products had undergone clinical trials. This revelation immediately changed the tone of the room.
Pawanjot explained that the formulations were based on ancient ayurvedic texts and traditional practices, which have been trusted for generations.
But the Sharks pushed back hard.
Trust and Responsibility in Health Products
For products that directly impact health, the Sharks emphasized that tradition alone is not enough.
Why the Sharks Were Concerned
Ayurveda may be ancient, but modern consumers expect scientific validation, especially when products are sold at scale. Without clinical trials or modern testing, it becomes difficult to verify safety, efficacy, and consistency.
The Sharks were clear: when you sell health solutions, you carry a responsibility that goes beyond revenue.
“Pehle Vishwas Banao”: The Line That Ended the Deal
Kunal Bahl was the first to opt out.
A Powerful Exit Statement
He acknowledged the founders’ ability to build a large business but made it clear why he could not invest. Trust, he said, must come before treatment.
“Pehle vishwas banao,” he stated—a line that summed up the entire pitch.
One by one, the remaining Sharks echoed similar concerns. Despite strong sales, none were willing to overlook the lack of validation and clarity.
Why High Revenue Couldn’t Save the Pitch
Ayuvya’s rejection was not about poor execution or lack of demand. It was about credibility.
Key Reasons the Sharks Walked Away
-
Unclear answers around growth rate and repeat customers
-
Weak justification for marketing quality
-
No clinical trials for health-related products
-
Overreliance on tradition without modern validation
-
A valuation that left little room for perceived risk
In the end, the Sharks felt the business carried too much uncertainty for a category that demands trust.
A Lesson for Health and Wellness Startups
Ayuvya’s pitch serves as a powerful case study for founders in the wellness space.
Revenue Is Not the Finish Line
Strong sales can open doors, but they don’t automatically guarantee investor confidence. In health-related businesses, transparency, validation, and responsibility are just as important as growth.
Investors want to know not just how fast a company is growing, but whether it deserves long-term trust.
What Ayuvya Can Learn Going Forward
Despite leaving without a deal, the founders gained something valuable: direct feedback from experienced investors.
If Ayuvya invests in clinical validation, improves data transparency, and strengthens its brand credibility, it could return stronger—whether on Shark Tank or in the broader market.
The Bigger Picture
Shark Tank India has repeatedly shown that flashy numbers don’t guarantee success in the Tank. Ayuvya’s journey reinforced a core principle of investing: trust is non-negotiable, especially in healthcare and wellness.
For viewers and founders alike, the message was clear. Growth gets attention, but responsibility earns belief—and without belief, even Rs 51 crore in revenue may not be enough.
